human blood coagulation factor ix lyophilized
ItalyDrugs containing this active substance
-
It is used for the treatment and prevention (prophylaxis) of bleeding in patients with hemophilia B (a factor IX deficiency present from birth) and for the treatment of acquired factor IX deficiency.
Form: solution for infusion, powder and solvent for preparation
Active substance Dosage human blood coagulation factor ix lyophilized - ATC: B02BD04
Manufacturer: KEDRION S.P.A.
-
It is used for the treatment and prevention (prophylaxis) of bleeding episodes in people with congenital hemophilia B, a hereditary disease that causes severe bleeding in the joints, muscles, or internal organs.
Form: solution for injection, powder and solvent
Active substance Dosage human blood coagulation factor ix lyophilized - ATC: B02BD04
Manufacturer: BAXALTA INNOVATIONS GMBH
-
It is used for the treatment and prevention of bleeding in the event of an acquired deficiency of coagulation factors (for example, caused by vitamin K antagonists or their overdose) or in the event of a congenital deficiency of certain coagulation factors when the specific product is not available.
Form: solution for infusion, powder and solvent for preparation
Active substance Dosage human blood coagulation factor ix lyophilized - coagulation factor ii - blood coagulation factor x - ATC: B02BD
Manufacturer: KEDRION S.P.A.